Business / Finance

RSS
Australian company accelerating the speed of drug discovery wins prestigious Eureka prize

Australian company accelerating the speed of drug discovery wins prestigious Eureka prize

Inventia Life Science partners with Xylyx Bio to develop tissue-specific, digitally-printed bioinks for drug discovery

Inventia Life Science partners with Xylyx Bio to develop tissue-specific, digitally-printed bioinks for drug discovery

Inventia Life Science and BioLamina partner to advance cell matrices for complex 3D cell models

Inventia Life Science and BioLamina partner to advance cell matrices for complex 3D cell models

RASTRUM™ - the 3D Printer of Living Cells, Honored in Annual Awards by Leading Business Magazine

RASTRUM™ - the 3D Printer of Living Cells, Honored in Annual Awards by Leading Business Magazine

Inventia Life Science Announces Partnership with PhenoVista Biosciences to Accelerate Preclinical Research with 3D Cell Models

Inventia Life Science Announces Partnership with PhenoVista Biosciences to Accelerate Preclinical Research with 3D Cell Models

Evonetix commences early access program for DNA synthesised by thermal control on its semiconductor chip

Evonetix commences early access program for DNA synthesised by thermal control on its semiconductor chip

CN Bio opens new laboratory facilities to extend Organ-on-a-chip contract research services capabilities

CN Bio opens new laboratory facilities to extend Organ-on-a-chip contract research services capabilities

INTEGRA pipettes simplify PCR testing for COVID-19

INTEGRA pipettes simplify PCR testing for COVID-19

INTEGRA solutions helping to support a new generation of RNA sequencing

INTEGRA solutions helping to support a new generation of RNA sequencing

Affordable Advanced Rapid Diagnostics from Global Access Diagnostics (GADx)

Affordable Advanced Rapid Diagnostics from Global Access Diagnostics (GADx)

seqWell appoints Dr Amy Liao to Board of Directors

seqWell appoints Dr Amy Liao to Board of Directors

Spirea raises £2.4M ($3M) to develop antibody drug conjugates   in cancer

Spirea raises £2.4M ($3M) to develop antibody drug conjugates in cancer

bit.bio launches Huntington’s disease human cell model

bit.bio launches Huntington’s disease human cell model

Sartorius Launches the Octet® SF3 SPR System, Strengthening its Leadership in Advanced Label-Free Bioanalytics

Sartorius Launches the Octet® SF3 SPR System, Strengthening its Leadership in Advanced Label-Free Bioanalytics

Dotmatics, previously Insightful Science, set to transform the future of scientific software and data management

Dotmatics, previously Insightful Science, set to transform the future of scientific software and data management

CN Bio introduces PhysioMimix NASH ‘in-a-box’ reagent kit

CN Bio introduces PhysioMimix NASH ‘in-a-box’ reagent kit

INTEGRA commits to sustainability

INTEGRA commits to sustainability

Venomtech announces new drug development collaboration with Charles River

Venomtech announces new drug development collaboration with Charles River

VectorBuilder to expand with $500 million ‘Gene Delivery Research and Manufacturing Campus

VectorBuilder to expand with $500 million ‘Gene Delivery Research and Manufacturing Campus

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.